Cargando…
Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy
The incidence and prevalence of diabetes mellitus (DM) are increasing worldwide, and the resulting cardiac complications are the leading cause of death. Among these complications is diabetes-induced cardiomyopathy (DCM), which is the consequence of a pro-inflammatory condition, oxidative stress and...
Autores principales: | da Silva, Jaqueline S., Gonçalves, Renata G. J., Vasques, Juliana F., Rocha, Bruna S., Nascimento-Carlos, Bianca, Montagnoli, Tadeu L., Mendez-Otero, Rosália, de Sá, Mauro P. L., Zapata-Sudo, Gisele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773977/ https://www.ncbi.nlm.nih.gov/pubmed/35053356 http://dx.doi.org/10.3390/cells11020240 |
Ejemplares similares
-
Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases
por: Gubert, Fernanda, et al.
Publicado: (2021) -
Heart Failure in Menopause: Treatment and New Approaches
por: da Silva, Jaqueline S., et al.
Publicado: (2022) -
Therapeutic Benefit of the Association of Lodenafil with Mesenchymal Stem Cells on Hypoxia-induced Pulmonary Hypertension in Rats
por: da Silva, Marina de Moraes Carvalho, et al.
Publicado: (2020) -
Diabetes-Induced Cardiac Autonomic Neuropathy: Impact on Heart Function and Prognosis
por: Sudo, Susumu Z., et al.
Publicado: (2022) -
Estrogen Receptors: Therapeutic Perspectives for the Treatment of Cardiac Dysfunction after Myocardial Infarction
por: da Silva, Jaqueline S., et al.
Publicado: (2021)